EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Unidentified CYP2D6 genotype does not affect pharmacological treatment for patients with first episode psychosis

Emma Y De Brabander iD, Thérèse van Amelsvoort, Roos van Westrhenen, GROUP Investigators

Journal of Psychopharmacology · 2024

DOI: 10.1177/02698811241279022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Psychopharmacology, 2024. Verfasst von Emma Y De Brabander und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Neuropsychology, Mental Health and Neuroscience Research Institute, Maastricht University Medical Centre, The Netherland…. Hauptthemen laut MEDLINE: Cytochrome P-450 CYP2D6, Psychotic Disorders, Antipsychotic Agents, Genotype. Die Arbeit nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Horizon 2020 Framework Programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Research on the pharmacogenetic influence of hepatic CYP450 enzyme 2D6 ( CYP2D6 ) on metabolism of drugs for psychosis and associated outcome has been inconclusive. Some results suggest increased risk of adverse reactions in poor and intermediate metabolizers, while others find no relationship. However, retrospective designs may fail to account for the long-term pharmacological treatment of patients. Previous studies found that clinicians adapted risperidone dose successfully without knowledge of patient CYP2D6 phenotype.

Aim

Here, we aimed to replicate the results of those studies in a Dutch cohort of patients with psychosis ( N = 418) on pharmacological treatment.

Method

We compared chlorpromazine-equivalent dose between CYP2D6 metabolizer phenotypes and investigated which factors were associated with dosage. This was repeated in two smaller subsets; patients prescribed pharmacogenetics-actionable drugs according to published guidelines, and risperidone-only as done previously.

Results

We found no relationship between chlorpromazine-equivalent dose and phenotype in any sample (complete sample: p = 0.3, actionable-subset: p = 0.82, risperidone-only: p = 0.34). Only clozapine dose was weakly associated with CYP2D6 phenotype ( p = 0.03).

Conclusion

Clinicians were thus not intuitively adapting dose to CYP2D6 activity in this sample, nor was CYP2D6 activity associated with prescribed dose. Although the previous studies could not be replicated, this study may provide support for existing and future pharmacogenetic research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytochrome P-450 CYP2D6Psychotic DisordersAntipsychotic AgentsGenotypeRisperidoneHumansFemaleMaleAdultYoung AdultPhenotypeChlorpromazineNetherlandsClozapineRetrospective StudiesPharmacogeneticsMiddle AgedAdolescent

Stichwörter der Autor:innen

CYP2D6Pharmacogeneticsdrugs for psychosispsychosis

Substanzen

Cytochrome P-450 CYP2D6Antipsychotic AgentsRisperidoneChlorpromazineClozapine

Autor:innen und Institutionen

  • Department of Psychiatry and Neuropsychology, Mental Health and Neuroscience Research Institute, Maastricht University Medical Centre, The Netherlands.
  • Department of Psychiatry, Parnassia Groep BV, The Netherlands.
  • Institute of Psychiatry, Psychology and Neurosciences, King's College London, London, UK.
  • St. John's National Academy of Health Sciences, Bangalore, India.

ORCID-Profile: Emma Y De Brabander

Förderung

  • Horizon 2020 Framework Programme

Zitieren

APA

De Brabander, E. Y., van Amelsvoort, T., van Westrhenen, R., & GROUP Investigators (2024). Unidentified CYP2D6 genotype does not affect pharmacological treatment for patients with first episode psychosis. Journal of Psychopharmacology. https://doi.org/10.1177/02698811241279022

Vancouver

De Brabander EY, van Amelsvoort T, van Westrhenen R, GROUP Investigators. Unidentified CYP2D6 genotype does not affect pharmacological treatment for patients with first episode psychosis. Journal of Psychopharmacology. 2024. doi:10.1177/02698811241279022

BibTeX
@article{DeBrabander2024,
  author = {De Brabander, Emma Y and van Amelsvoort, Thérèse and van Westrhenen, Roos and GROUP Investigators, GROUP Investigators},
  title = {Unidentified CYP2D6 genotype does not affect pharmacological treatment for patients with first episode psychosis},
  journal = {Journal of Psychopharmacology},
  year = {2024},
  doi = {10.1177/02698811241279022}
}
Kostenlos starten →